Shares of Medicure Inc. (CVE:MPH – Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$0.86 and traded as low as C$0.72. Medicure shares last traded at C$0.72, with a volume of 7,500 shares changing hands.
Medicure Trading Down 5.3 %
The company has a debt-to-equity ratio of 2.06, a quick ratio of 1.29 and a current ratio of 1.87. The stock has a market capitalization of C$7.52 million, a P/E ratio of -2.88 and a beta of 0.90. The firm’s fifty day simple moving average is C$0.86 and its 200 day simple moving average is C$0.94.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- How to Calculate Inflation Rate
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Earnings Per Share Calculator: How to Calculate EPS
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Roth IRA Calculator: Calculate Your Potential Returns
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
